Jpmorgan Chase & CO Prothena Corp Public LTD CO Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Jpmorgan Chase & CO holds 199,986 shares of PRTA stock, worth $2.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

199,986

Previous 295,965 32.43%

Holding current value

$2.88 Million

Previous $6.11 Million 45.24%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$16.73 - $24.79 $1.61 Million - $2.38 Million	-95,979 Reduced 32.43%	199,986 $3.35 Million
Q2 2024 Aug 12, 2024	SELL	$19.54 - $26.15 $41,542 - $55,594	-2,126 Reduced 0.71%	295,965 $6.11 Million
Q1 2024 May 10, 2024	SELL	$24.75 - $40.66 $1.49 Million - $2.46 Million	-60,387 Reduced 16.85%	298,091 $7.38 Million
Q4 2023 Feb 12, 2024	SELL	$32.31 - $52.32 $1.41 Million - $2.28 Million	-43,553 Reduced 10.83%	358,478 $13 Million
Q3 2023 Nov 14, 2023	SELL	$47.3 - $70.6 $569,208 - $849,600	-12,034 Reduced 2.91%	402,031 $19.4 Million
Q2 2023 Aug 11, 2023	BUY	$48.26 - $78.59 $4.17 Million - $6.79 Million	86,347 Added 26.35%	414,065 $28.3 Million
Q1 2023 May 18, 2023	BUY	$46.97 - $58.27 $2.31 Million - $2.87 Million	49,259 Added 17.69%	327,718 $15.9 Million
Q1 2023 May 11, 2023	SELL	$46.97 - $58.27 $5.92 Million - $7.35 Million	-126,092 Reduced 31.17%	278,459 $13.5 Million
Q4 2022 Feb 13, 2023	BUY	$52.05 - $65.0 $6.37 Million - $7.95 Million	122,369 Added 43.37%	404,551 $24.4 Million
Q3 2022 Nov 14, 2022	SELL	$25.16 - $60.63 $110,628 - $266,590	-4,397 Reduced 1.53%	282,182 $17.1 Million
Q2 2022 Aug 11, 2022	BUY	$22.73 - $39.98 $782,798 - $1.38 Million	34,439 Added 13.66%	286,579 $7.78 Million
Q1 2022 May 11, 2022	BUY	$30.27 - $49.22 $1.11 Million - $1.81 Million	36,798 Added 17.09%	252,140 $9.22 Million
Q4 2021 Feb 10, 2022	BUY	$42.11 - $73.26 $8.47 Million - $14.7 Million	201,056 Added 1407.36%	215,342 $10.6 Million
Q3 2021 Nov 12, 2021	BUY	$48.2 - $78.89 $688,585 - $1.13 Million	14,286 New	14,286 $1.02 Million

Others Institutions Holding PRTA

# of Institutions

184

Shares Held

42.7M

Call Options Held

162K

Put Options Held

102K

View Full List

About PROTHENA CORP PUBLIC LTD CO

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $676M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

More about PRTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Prothena Corp Public LTD CO Transaction History